Market Overview

Foamix Pharmaceuticals (NASDAQ: FOMX)

3.70 -0.13 (-3.39%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/12/18Bank of AmericaInitiates Coverage OnBuy11.0
12/06/17GuggenheimInitiates Coverage OnBuy8.0
8/24/17H.C. WainwrightInitiates Coverage OnBuy12.0
2/15/17Credit SuisseInitiates Coverage OnOutperform22.0
4/16/15GuggenheimInitiates Coverage onBuy14.0
11/18/14Maxim GroupInitiates Coverage onBuy38.0
10/13/14BarclaysInitiates Coverage onOverweight11.0
10/13/14OppenheimerInitiates Coverage onOutperform15.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter